Related Experiment Video
Updated: May 8, 2026
05:00
Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
Changes in biomarkers associated with living kidney donation
Yonghong Huan1, Shiv Kapoor, Stephanie Deloach
1Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
American Journal of Nephrology
|August 31, 2013
Summary
Living kidney donation is safe, but may alter cardiovascular risk biomarkers. Kidney donors showed increased symmetric dimethylarginine and fibroblast growth factor 23 levels post-donation, indicating potential long-term health implications.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Transplant Surgery
Background:
- Living donor kidney transplantation improves recipient outcomes.
- Living kidney donation is generally safe but carries potential risks for donors.
- Concerns exist regarding long-term cardiovascular health in living kidney donors.
Purpose of the Study:
- To investigate changes in cardiovascular biomarkers after living kidney donation.
- To assess the impact of kidney donation on donor health.
- To identify potential early indicators of cardiovascular risk in living kidney donors.
Main Methods:
- Analysis of serum biomarkers in 34 healthy living kidney donors.
- Measurement of traditional and novel cardiovascular biomarkers.
- Comparison of biomarker levels at baseline and 6 months post-donation.
Main Results:
- Estimated glomerular filtration rate (GFR) significantly decreased from 86 to 60 ml/min/1.73 m(2).
- No significant changes in body mass index or blood pressure were observed.
- Levels of symmetric dimethylarginine and fibroblast growth factor 23 significantly increased post-donation.
Conclusions:
- Living kidney donation can lead to significant changes in cardiovascular risk biomarkers.
- Elevated symmetric dimethylarginine and fibroblast growth factor 23 may indicate increased cardiovascular risk.
- Further research is needed to understand the long-term implications for living kidney donors.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...